Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 276

The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.

Vaccination induces HIV broadly neutralizing antibody precursors in humans

Open access
Leggat, David J., Cohen, Kristen W., Willis, Jordan R., Fulp, William J., deCamp, Allan C., Kalyuzhniy, Oleksandr, Cottrell, Christopher A., Menis, Sergey, Finak, Greg, Ballweber-Fleming, Lamar, Srikanth, Abhinaya, Plyler, Jason R., Schiffner, Torben, Liguori, Alessia, Rahaman, Farhad, Lombardo, Angela, Philiponis, Vincent, Whaley, Rachael E., Seese, Aaron, Brand, Joshua, Ruppel, Alexis M., Hoyland, Wesley, Yates, Nicole L., Williams, LaTonya D., Greene, Kelli, Gao, Hongmei, Mahoney, Celia R., Corcoran, Martin M., Cagigi, Alberto, Taylor, Alison, Brown, David M., Ambrozak, David R., Sincomb, Troy, Hu, Xiaozhen, Tingle, Ryan, Georgeson, Erik, Eskandarzadeh, Saman, Alavi, Nushin, Lu, Danny, Mullen, Tina-Marie, Kubitz, Michael, Groschel, Bettina, Maenza, Janine, Kolokythas, Orpheus, Khati, Nadia, Bethony, Jeffrey, Crotty, Shane, Roederer, Mario, Karlsson Hedestam, Gunilla B., Tomaras, Georgia D., Montefiori, David, Diemert, David, Koup, Richard A., Laufer, Dagna S., McElrath, M. Juliana, McDermott, Adrian B., Schief, William R.·2022·Science

Abstract

Broadly neutralizing antibodies (bnAbs) can protect against HIV infection but have not been induced by human vaccination. A key barrier to bnAb induction is vaccine priming of rare bnAb-precursor B cells. In a randomized, double-blind, placebo-controlled phase 1 clinical trial, the HIV vaccine–priming candidate eOD-GT8 60mer adjuvanted with AS01 B had a favorable safety profile and induced VRC01-class bnAb precursors in 97% of vaccine recipients with median frequencies reaching 0.1% among immunoglobulin G B cells in blood. bnAb precursors shared properties with bnAbs and gained somatic hypermutation and affinity with the boost. The results establish clinical proof of concept for germline-targeting vaccine priming, support development of boosting regimens to induce bnAbs, and encourage application of the germline-targeting strategy to other targets in HIV and other pathogens.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1126/science.add6502

Cites

111 of 111 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 111 references

Cited by

See all 276

Metadata

Authors
Leggat, D. J., Cohen, K. W., Willis, J. R., Fulp, W. J., deCamp, A. C., Kalyuzhniy, O., Cottrell, C. A., Menis, S., Finak, G., Ballweber-Fleming, L., Srikanth, A., Plyler, J. R., Schiffner, T., Liguori, A., Rahaman, F., Lombardo, A., Philiponis, V., Whaley, R. E., Seese, A., Brand, J., Ruppel, A. M., Hoyland, W., Yates, N. L., Williams, L. D., Greene, K., Gao, H., Mahoney, C. R., Corcoran, M. M., Cagigi, A., Taylor, A., Brown, D. M., Ambrozak, D. R., Sincomb, T., Hu, X., Tingle, R., Georgeson, E., Eskandarzadeh, S., Alavi, N., Lu, D., Mullen, T.-M., Kubitz, M., Groschel, B., Maenza, J., Kolokythas, O., Khati, N., Bethony, J., Crotty, S., Roederer, M., Karlsson Hedestam, G. B., Tomaras, G. D., Montefiori, D., Diemert, D., Koup, R. A., Laufer, D. S., McElrath, M. J., McDermott, A. B., & Schief, W. R.
Venue
Science
Published
2022-12-02
Volume
378
Issue
6623
Pages
eadd6502-eadd6502
ISSN
  • 0036-8075 (ISSN-L)
  • 1095-9203
OpenAlex
W4310707361
Cited by
276
References
111
FWCI
15.59
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Vaccination induces HIV broadly neutralizing antibody precursors in humans. https://app.cochat.ai/papers/10.1126/science.add6502
The paper
Leggat, D. J., Cohen, K. W., Willis, J. R., Fulp, W. J., deCamp, A. C., Kalyuzhniy, O., Cottrell, C. A., Menis, S., Finak, G., Ballweber-Fleming, L., Srikanth, A., Plyler, J. R., Schiffner, T., Liguori, A., Rahaman, F., Lombardo, A., Philiponis, V., Whaley, R. E., Seese, A., . . . Schief, W. R. (2022). Vaccination induces HIV broadly neutralizing antibody precursors in humans. Science. https://doi.org/10.1126/science.add6502

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.